Tag: Clinical trials

STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy

CHICAGO — Lipoprotein(a), a genetic risk factor for cardiovascular disease carried by 1 in 5 people, is the target...

STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories

CHICAGO — Out-of-control inflammation is often called the root of all evil in cardiovascular and metabolic disease. Recent clinical...

STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test

The French pharma Servier said Tuesday that an experimental drug it purchased in June for $1.55 billion in cash,...